Clinical Trial Update: Atorvastatin After Aneurysmal Subarachnoid Hemorrhage

View source ↗

Summary

The clinical trial update reports the completion of a study evaluating atorvastatin after aneurysmal subarachnoid hemorrhage (SAH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: SAH | Status: COMPLETED